FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop

FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop The Federal Trade Commission and the U.S. Department of Justice, Antitrust Division released a summary of a two-day workshop that explored new approaches to enforcement of the antitrust laws in the pharmaceutical industry. View Press Release More news from the FTC

---

To update or delete your subscription at any time, visit your subscriber preferences page. If you have questions or problems with the subscription service, please contact subscriber support. This is a free service provided by the Federal Trade Commission.

---

This email was sent to jtrent238.test@blogger.com using GovDelivery Communications Cloud on behalf of: Federal Trade Commission · 600 Pennsylvania Ave., NW · Washington, DC 20580 · 1-877-382-4357